Dublin, March 18, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/wh78nb/biochips_global) has announced the addition of the "Biochips - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020.
This report analyzes the worldwide markets for Biochips in US$ Million by the following Segments: DNA Biochips, Protein Biochips, Lab-on-a-Chip, and Others.
The report further analyzes the market by the following Applications: Research, Diagnostics, and Others.
Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 79 companies including many key and niche players such as
- Affymetrix, Inc. (US)
- Agilent Technologies, Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- Cepheid Inc. (US)
- Fluidigm Corporation (US)
- GE Healthcare Ltd. (UK)
- Hoffman-La-Roche Ltd. (Switzerland)
- Illumina, Inc. (US)
- Ocimum Biosolutions Ltd. (India)
- PerkinElmer, Inc. (US)
- Takara Bio, Inc. (Japan)
- Clontech Laboratories, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
Key Topics Covered:
1. INDUSTRY OVERVIEW
2. INNOVATIONS IN THE BIOCHIPS INDUSTRY
3. COMPETITION
4. PRODUCT OVERVIEW
5. BIOCHIP AND MICROARRAY CONSTRUCTION
6. APPLICATIONS OF BIOCHIPS
7. PRODUCT INTRODUCTIONS
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT GLOBAL PLAYERS
10. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 79 (including Divisions/Subsidiaries 86)
- The United States (45)
- Canada (2)
- Japan (6)
- Europe (22)
- - France (2)
- - Germany (6)
- - The United Kingdom (3)
- - Spain (2)
- - Rest of Europe (9)
- Asia-Pacific (Excluding Japan) (10)
- Middle East (1)
For more information visit http://www.researchandmarkets.com/research/wh78nb/biochips_global
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
John Ternus Signals Apple’s Future with Product-First AI Strategy
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 



